Thus, we speculate that, dependent on the individual lung milieu, anti-CD73 therapy may impact specific DC subsets and thereby inducing stronger pro-inflammatory cytokine and ROS production and enhancing the risk for radiation pneumonitis. The gene discussed is NT5E; the disease is radiation pneumonitis.